[go: up one dir, main page]

CN114773253A - Preparation method of polysubstituted arylamine compound - Google Patents

Preparation method of polysubstituted arylamine compound Download PDF

Info

Publication number
CN114773253A
CN114773253A CN202210580811.8A CN202210580811A CN114773253A CN 114773253 A CN114773253 A CN 114773253A CN 202210580811 A CN202210580811 A CN 202210580811A CN 114773253 A CN114773253 A CN 114773253A
Authority
CN
China
Prior art keywords
preparation
derivatives
benzyl halide
reaction
aromatic amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202210580811.8A
Other languages
Chinese (zh)
Inventor
包明
王瑛琦
张胜
冯秀娟
于晓强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University of Technology
Original Assignee
Dalian University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University of Technology filed Critical Dalian University of Technology
Priority to CN202210580811.8A priority Critical patent/CN114773253A/en
Publication of CN114773253A publication Critical patent/CN114773253A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明属于医药化工中间体及相关化学技术领域,提供了一种多取代芳胺类化合物的制备方法,以含苄基卤化物及其衍生物为原料,在金属催化剂、配体,碱的作用下,在无水有机溶剂与胺类化合物发生反应,得到相应的多取代芳香胺类化合物。本发明的有益效果是该方法的合成路线短、反应条件温和、操作简便,高收率;所得芳胺产物可以进行多种官能化,如溴代反应,反应产物可以应用于多种功能材料和药物分子的合成。

Figure 202210580811

The invention belongs to the field of pharmaceutical chemical intermediates and related chemical technologies, and provides a method for preparing a polysubstituted aromatic amine compound. Under the following conditions, react with an amine compound in an anhydrous organic solvent to obtain the corresponding polysubstituted aromatic amine compound. The beneficial effects of the present invention are that the method has a short synthetic route, mild reaction conditions, simple operation and high yield; the obtained aromatic amine product can be subjected to various functionalizations, such as bromination reaction, and the reaction product can be applied to various functional materials and Synthesis of drug molecules.

Figure 202210580811

Description

一种多取代芳胺类化合物的制备方法A kind of preparation method of polysubstituted aromatic amine compound

技术领域technical field

本发明属于医药化工中间体及相关化学技术领域,提供了一种高效的多取代芳香胺类化合物的制备方法。The invention belongs to the field of pharmaceutical chemical intermediates and related chemical technologies, and provides an efficient preparation method of polysubstituted aromatic amine compounds.

背景技术Background technique

芳胺化合物因具有独特电子性质,在医药、天然产物、发光材料等领域,都有着很重要的应用价值,并广泛存在于已有的药物分子中。而多取代芳胺类结构在的构筑则尤为重要。Because of their unique electronic properties, arylamine compounds have important application value in the fields of medicine, natural products, and luminescent materials, and are widely present in existing drug molecules. The construction of polysubstituted aromatic amines is particularly important.

已经报道的合成芳胺类化合物的合成方法按照催化体系的种类分成了两种,一种是以芳烃为原料的无金属催化剂的直接硝化、还原法。然而反应需要大量的金属试剂(如铁粉)、过量酸试剂、苛刻的反应条件,这些因素严重的限制了这一方法在构筑多取代芳胺的应用,同时也会有害环境的。另一种是以芳烃为原料的通过过渡金属钯、铜等催化的偶联反应。最为常见的有Buchwald-Hartwig交叉偶联反应[Org Process Res Dev,2019,23(8):1478-83]、Ullmann胺化反应[Prog Chem,2018,30(9):1257-97;Chem Soc Rev,2014,43(10):3525-50]、Chan-Lam胺化反应[Chem Rev,2019,119(24):12491-523]。The reported synthetic methods for synthesizing aromatic amine compounds are divided into two types according to the type of catalytic system. One is the direct nitration and reduction method using aromatic hydrocarbons as raw materials without metal catalysts. However, the reaction requires a large amount of metal reagents (such as iron powder), excess acid reagents, and harsh reaction conditions. These factors severely limit the application of this method in the construction of polysubstituted aromatic amines, and are also harmful to the environment. The other is a coupling reaction catalyzed by transition metal palladium, copper, etc., using aromatic hydrocarbons as raw materials. The most common are Buchwald-Hartwig cross-coupling reaction [Org Process Res Dev, 2019, 23(8): 1478-83], Ullmann amination reaction [Prog Chem, 2018, 30(9): 1257-97; Chem Soc Rev, 2014, 43(10):3525-50], Chan-Lam amination reaction [Chem Rev, 2019, 119(24):12491-523].

Buchwald-Hartwig交叉偶联反应,在钯催化剂的存在下,卤代芳烃可以与不同的胺进行反应构筑芳胺类化合物。但经历了多年的发展,仍没有一种催化体系可以用于不同芳胺类底物的构筑,并且仅卤代芳烃与胺进行反应。In the Buchwald-Hartwig cross-coupling reaction, in the presence of palladium catalysts, halogenated aromatic hydrocarbons can react with different amines to construct aromatic amine compounds. However, after years of development, there is still no catalytic system that can be used for the construction of different aromatic amine substrates, and only halogenated aromatic hydrocarbons are reacted with amines.

Ullmann反应,使用卤代芳烃和不同胺化合物在过量的铜催化剂下实现芳胺类化合物的构筑。但过高的反应温度,复杂的配体体系,模糊的反应机理都限制了Ullmann反应在多取代芳胺构筑方面的应用。Ullmann reaction, the use of halogenated aromatic hydrocarbons and different amine compounds in the presence of excess copper catalyst to achieve the construction of aromatic amine compounds. However, the high reaction temperature, complex ligand system and ambiguous reaction mechanism limit the application of Ullmann reaction in the construction of polysubstituted aromatic amines.

Chan-Lam胺化反应,在铜催化剂的存在下,使用硼酸化合物与胺类化合物构筑芳胺类化合物。但反应需要当量的氧化剂作为辅助,且必须使用有机硼酸试剂作为底物都限制了Chan-Lam胺化反应在构筑多取代芳胺方面的应用。In Chan-Lam amination reaction, in the presence of copper catalyst, boronic acid compounds and amine compounds are used to construct aromatic amine compounds. However, the reaction requires an equivalent amount of oxidant as an auxiliary and must use an organic boronic acid reagent as a substrate, which limits the application of the Chan-Lam amination reaction in the construction of polysubstituted aromatic amines.

近年来,通过过渡金属去芳构化策略构筑功能分子的方法因其反应条件温和,易于制取复杂功能分子等优点,越来越为人们所看好。截至目前,以苄基卤代物及其衍生物作为反应底物直接获得多取代芳胺类化合物的合成方法还未见报道。In recent years, the method of constructing functional molecules by transition metal dearomatization strategy has become more and more promising due to its mild reaction conditions and easy preparation of complex functional molecules. Up to now, there has been no report on the synthesis method of directly obtaining polysubstituted arylamines using benzyl halides and their derivatives as reaction substrates.

发明内容SUMMARY OF THE INVENTION

本发明提供了一种多取代芳胺类化合物的制备方法,该制备方法具有反应条件温和、反应选择性好、底物范围宽泛等优点。The invention provides a preparation method of a polysubstituted aromatic amine compound. The preparation method has the advantages of mild reaction conditions, good reaction selectivity, wide substrate range and the like.

本发明的技术方案如下:The technical scheme of the present invention is as follows:

一种高效的多取代芳胺类化合物的制备方法,其特征在于,以苄基卤代物及其衍生物为原料,在碱、钯催化剂、配体的共同作用下,在无水有机溶剂中,与含氮化合物反应,即可制备相应的多取代芳胺类化合物,合成路线如下:An efficient preparation method of polysubstituted aromatic amine compounds is characterized in that, using benzyl halide and derivatives thereof as raw materials, under the joint action of alkali, palladium catalyst and ligand, in anhydrous organic solvent, The corresponding polysubstituted aromatic amine compounds can be prepared by reacting with nitrogen-containing compounds. The synthetic route is as follows:

Figure BDA0003663655340000021
Figure BDA0003663655340000021

反应温度在40℃,反应时间12h;The reaction temperature was 40°C, and the reaction time was 12h;

R1选自氢、芳基;R 1 is selected from hydrogen, aryl;

R2选自氢、甲氧基、芳基;R 2 is selected from hydrogen, methoxy, aryl;

R3为芳基;R 3 is aryl;

R4为烷基;R 4 is alkyl;

R5为烷基;R 5 is alkyl;

X选自氯、溴;X is selected from chlorine, bromine;

苄基卤代物及其衍生物与碱的摩尔比为1:4;The molar ratio of benzyl halide and its derivatives to base is 1:4;

苄基卤代物及其衍生物与金属催化剂的摩尔比为1:0.05;The molar ratio of benzyl halide and its derivatives to metal catalyst is 1:0.05;

苄基卤代物及其衍生物与配体的摩尔比为1:0.2;The molar ratio of benzyl halide and its derivatives to ligand is 1:0.2;

苄基卤代物及其衍生物的摩尔浓度为0.06mmol/mL;The molar concentration of benzyl halide and its derivatives is 0.06mmol/mL;

苄基卤代物及其衍生物与胺类化合物的摩尔比为1:2;The molar ratio of benzyl halide and its derivative to amine compound is 1:2;

所述的胺类化合物为一元胺化合物和二元胺化合物;The amine compounds are monoamine compounds and diamine compounds;

所述的碱为氢化钠;Described alkali is sodium hydride;

所述的金属催化剂为醋酸钯、二(乙酰丙酮)钯;Described metal catalyst is palladium acetate, two (acetylacetonate) palladium;

所述的配体包括三(2-呋喃基)磷、三[2-(5-甲基呋喃基)]膦、三[2-(5-乙基呋喃基)]膦、三(2-噻吩基)膦;The ligands include tris(2-furyl)phosphorus, tris[2-(5-methylfuryl)]phosphine, tris[2-(5-ethylfuryl)]phosphine, tris(2-thiophene) base) phosphine;

所述的无水有机溶剂为四氢呋喃;Described anhydrous organic solvent is tetrahydrofuran;

分离方法包括柱层析、重结晶等;Separation methods include column chromatography, recrystallization, etc.;

重结晶一般使用的溶剂包括正己烷、石油醚、丙酮、水。Commonly used solvents for recrystallization include n-hexane, petroleum ether, acetone, and water.

用柱层析法对产物进行分离时,可以使用硅胶或者中性氧化铝作为固定相,展开剂一般为纯溶剂,如石油醚、正己烷、二氯甲烷、乙酸乙酯、甲醇;或是两种不同极性溶剂混合而得,如乙酸乙酯-石油醚、乙酸乙酯-正己烷、二氯甲烷-石油醚、甲醇-乙酸乙酯、甲醇-二氯甲烷。When the product is separated by column chromatography, silica gel or neutral alumina can be used as the stationary phase, and the developing solvent is generally a pure solvent, such as petroleum ether, n-hexane, dichloromethane, ethyl acetate, methanol; or two. It is obtained by mixing different polar solvents, such as ethyl acetate-petroleum ether, ethyl acetate-n-hexane, dichloromethane-petroleum ether, methanol-ethyl acetate, methanol-dichloromethane.

本发明的有益效果是该方法的合成路线短、反应条件温和、操作简便,高收率;所得胺化产物可以进行多种官能化,如溴代反应,反应产物可以应用于多种功能材料和药物分子的合成。The beneficial effects of the present invention are that the synthesis route of the method is short, the reaction conditions are mild, the operation is simple and the yield is high; the obtained amination product can be subjected to various functionalizations, such as bromination reaction, and the reaction product can be applied to various functional materials and Synthesis of drug molecules.

附图说明Description of drawings

图1是实施例1中4,4-二氟-1-(4-甲基-3-苯基苯基)哌啶的1H核磁谱图。FIG. 1 is the 1 H nuclear magnetic spectrum of 4,4-difluoro-1-(4-methyl-3-phenylphenyl)piperidine in Example 1. FIG.

图2是实施例1中4,4-二氟-1-(4-甲基-3-苯基苯基)哌啶的13C核磁谱图。2 is a 13 C nuclear magnetic spectrum of 4,4-difluoro-1-(4-methyl-3-phenylphenyl)piperidine in Example 1.

图3是实施例2中2-苯基-4-(4-苯甲酰基哌嗪基)甲苯的1H核磁谱图。FIG. 3 is the 1 H nuclear magnetic spectrum of 2-phenyl-4-(4-benzoylpiperazinyl)toluene in Example 2. FIG.

图4是实施例2中2-苯基-4-(4-苯甲酰基哌嗪基)甲苯的13C核磁谱图。4 is a 13 C nuclear magnetic spectrum of 2-phenyl-4-(4-benzoylpiperazinyl)toluene in Example 2.

图5是实施例3中5-甲氧基-4-吗啉基-2-苯基甲苯的1H核磁谱图。FIG. 5 is the 1 H nuclear magnetic spectrum of 5-methoxy-4-morpholinyl-2-phenyltoluene in Example 3. FIG.

图6是实施例3中5-甲氧基-4-吗啉基-2-苯基甲苯的13C核磁谱图。FIG. 6 is a 13 C nuclear magnetic spectrum of 5-methoxy-4-morpholinyl-2-phenyltoluene in Example 3. FIG.

图7是实施例4中4-吗啉基-2,5-二苯基甲苯的1H核磁谱图。FIG. 7 is a 1 H nuclear magnetic spectrum of 4-morpholinyl-2,5-diphenyltoluene in Example 4. FIG.

图8是实施例4中4-吗啉基-2,5-二苯基甲苯的13C核磁谱图。FIG. 8 is a 13 C nuclear magnetic spectrum of 4-morpholinyl-2,5-diphenyltoluene in Example 4. FIG.

图9是实施例5中4-吗啉基-2-(4-甲氧基苯基)甲苯的1H核磁谱图。FIG. 9 is the 1 H nuclear magnetic spectrum of 4-morpholinyl-2-(4-methoxyphenyl)toluene in Example 5. FIG.

图10是实施例5中4-吗啉基-2-(4-甲氧基苯基)甲苯13C核磁谱图。FIG. 10 is the 13 C nuclear magnetic spectrum of 4-morpholinyl-2-(4-methoxyphenyl)toluene in Example 5. FIG.

图11是对比例1中4-吗啉基-2-苯基甲苯的1H核磁谱图。FIG. 11 is the 1 H nuclear magnetic spectrum of 4-morpholinyl-2-phenyltoluene in Comparative Example 1. FIG.

图12是对比例1中4-吗啉基-2-苯基甲苯的13C核磁谱图。FIG. 12 is a 13 C nuclear magnetic spectrum of 4-morpholinyl-2-phenyltoluene in Comparative Example 1. FIG.

具体实施方式Detailed ways

本发明所述的多取代芳胺类化合物的制备方法,具有原料价格低廉、反应步骤少、反应条件温和、操作简单和反应收率高等优点。The preparation method of the polysubstituted aromatic amine compound of the present invention has the advantages of low raw material price, few reaction steps, mild reaction conditions, simple operation and high reaction yield.

下面结合具体实施例,进一步阐述本发明。这些实施例仅用于说明本发明而不用于限制本发明的范围。在本领域内的技术人员对本发明所做的简单替换或改进均属于本发明所保护的技术方案之内。The present invention will be further described below in conjunction with specific embodiments. These examples are only intended to illustrate the present invention and not to limit the scope of the present invention. Simple replacements or improvements made to the present invention by those skilled in the art all fall within the technical solutions protected by the present invention.

实施例1:4,4-二氟-1-(4-甲基-3-苯基苯基)哌啶的合成Example 1: Synthesis of 4,4-difluoro-1-(4-methyl-3-phenylphenyl)piperidine

在25mL反应器中,加入氢化钠(0.0224g,1.2mmol),氮气置换三次后,加入无水四氢呋喃(5mL),并在搅拌下加入4,4-二氟哌啶(0.0727g,0.6mmol),搅拌一小时后,向其中依次加入三(2-呋喃基)膦(0.0139g,0.06mmol),醋酸钯(0.0034g,0.015mmol),2-苯基苄氯(0.0608g,0.3mmol);混合物在40℃下反应12小时。柱层析分离(硅胶,200-300目;展开剂,石油醚/乙酸乙酯=3/1,v/v),得4,4-二氟-1-(4-甲基-3-苯基苯基)哌啶0.074g,产率86%。In a 25 mL reactor, sodium hydride (0.0224 g, 1.2 mmol) was added, and after nitrogen replacement three times, anhydrous tetrahydrofuran (5 mL) was added, and 4,4-difluoropiperidine (0.0727 g, 0.6 mmol) was added under stirring. , and after stirring for one hour, tris(2-furyl)phosphine (0.0139g, 0.06mmol), palladium acetate (0.0034g, 0.015mmol), 2-phenylbenzyl chloride (0.0608g, 0.3mmol) were successively added thereto; The mixture was reacted at 40°C for 12 hours. Column chromatography (silica gel, 200-300 mesh; developing solvent, petroleum ether/ethyl acetate = 3/1, v/v) to obtain 4,4-difluoro-1-(4-methyl-3-benzene phenyl) piperidine 0.074 g, 86% yield.

Figure BDA0003663655340000051
4,4-二氟-1-(4-甲基-3-苯基苯基)哌啶
Figure BDA0003663655340000051
4,4-Difluoro-1-(4-methyl-3-phenylphenyl)piperidine

Colorless oil.1H NMR(400MHz,CDCl3)δ7.35–7.29(m,2H),7.28–7.21(m,3H),7.08(d,J=8.3Hz,1H),6.81–6.74(m,2H),3.27–3.21(m,4H),2.10(s,3H),2.06–1.95(m,4H).13C NMR(101MHz,CDCl3)δ148.3,142.8,142.3,131.1,129.1,128.1,126.9,118.7,116.0,47.2(2JC-F=5.0Hz),33.7(1JC-F=22.8Hz),19.5.19F NMR(377MHz,CDCl3)δ-97.6.IR(neat):υmax 3056,2966,2938,2831,1609,1561,1342,1197,925,773,703,633cm-1;HRMS(ESI)m/z calcd for C18H20F2N[M+H]+:288.1558,found:288.1550.Colorless oil. 1 H NMR (400 MHz, CDCl 3 ) δ 7.35-7.29 (m, 2H), 7.28-7.21 (m, 3H), 7.08 (d, J=8.3Hz, 1H), 6.81-6.74 (m, 2H), 3.27–3.21 (m, 4H), 2.10 (s, 3H), 2.06–1.95 (m, 4H). 13 C NMR (101 MHz, CDCl 3 ) δ 148.3, 142.8, 142.3, 131.1, 129.1, 128.1, 126.9 , 118.7, 116.0, 47.2 ( 2 J CF = 5.0 Hz), 33.7 ( 1 J CF = 22.8 Hz), 19.5. 19 F NMR (377 MHz, CDCl 3 ) δ-97.6. IR (neat): υ max 3056, 2966 ,2938,2831,1609,1561,1342,1197,925,773,703,633cm -1 ; HRMS(ESI) m/z calcd for C 18 H 20 F 2 N[M+H] + :288.1558,found:288.1550.

实施例2:2-苯基-4-(4-苯甲酰基哌嗪基)甲苯的合成Example 2: Synthesis of 2-phenyl-4-(4-benzoylpiperazinyl)toluene

在25mL反应器中,加入氢化钠(0.0224g,1.2mmol),氮气置换三次后,加入无水四氢呋喃(5mL),并在搅拌下加入1-苯甲酰基哌嗪,搅拌两小时后,向其中依次加入三[2-(5-甲基呋喃基)]膦(0.0165g,0.06mmol),二(乙酰丙酮)钯(0.0046g,0.015mmol),2-苯基苄氯(0.0608g,0.3mmol);混合物在40℃下反应12小时。柱层析分离(硅胶,200-300目;展开剂,石油醚/乙酸乙酯=1/1,v/v),得2-苯基-4-(4-苯甲酰基哌嗪基)甲苯0.076g,产率71%。In a 25 mL reactor, sodium hydride (0.0224 g, 1.2 mmol) was added, after nitrogen replacement three times, anhydrous tetrahydrofuran (5 mL) was added, and 1-benzoylpiperazine was added under stirring, and after stirring for two hours, added thereto Tris[2-(5-methylfuryl)]phosphine (0.0165g, 0.06mmol), bis(acetylacetonate)palladium (0.0046g, 0.015mmol), 2-phenylbenzyl chloride (0.0608g, 0.3mmol) were added successively ); the mixture was reacted at 40°C for 12 hours. Column chromatography separation (silica gel, 200-300 mesh; developing solvent, petroleum ether/ethyl acetate=1/1, v/v) to obtain 2-phenyl-4-(4-benzoylpiperazinyl)toluene 0.076 g, 71% yield.

Figure BDA0003663655340000052
2-苯基-4-(4-苯甲酰基哌嗪基)甲苯
Figure BDA0003663655340000052
2-Phenyl-4-(4-benzoylpiperazinyl)toluene

White solid.1H NMR(600MHz,CDCl3)δ7.41–7.30(m,7H),7.28–7.21(m,3H),7.11(d,J=8.3Hz,1H),6.78(d,J=25.9Hz,2H),3.69(d,J=214.3Hz,4H),3.11(d,J=87.8Hz,4H),2.11(s,3H).13C NMR(151MHz,CDCl3)δ170.4,149.0,142.7,142.2,135.7,131.1,129.9,129.1,128.6,128.1,127.2,126.9,118.6,116.0,50.2,47.7,42.1,19.5.IR(KBr):υmax 3019,2954,2924,1637,1431,1379,1264,1156,1013,942,737,704cm-1;HRMS(ESI)m/zcalcd for C24H25N2O[M+H]+:357.1961,found:357.1951.White solid. 1 H NMR (600 MHz, CDCl 3 ) δ 7.41–7.30 (m, 7H), 7.28–7.21 (m, 3H), 7.11 (d, J=8.3 Hz, 1H), 6.78 (d, J= 25.9Hz, 2H), 3.69(d, J=214.3Hz, 4H), 3.11(d, J=87.8Hz, 4H), 2.11(s, 3H). 13 C NMR(151MHz, CDCl 3 )δ170.4,149.0, 142.7,142.2,135.7,131.1,129.9,129.1,128.6,128.1,127.2,126.9,118.6,116.0,50.2,47.7,42.1,19.5.IR(KBr):υ max 3019,2954,2924,1637,1431 , 1264, 1156, 1013, 942, 737, 704 cm -1 ; HRMS(ESI) m/zcalcd for C 24 H 25 N 2 O[M+H] + : 357.1961, found: 357.1951.

实施例3:5-甲氧基-4-吗啉基-2-苯基甲苯的合成Example 3: Synthesis of 5-methoxy-4-morpholinyl-2-phenyltoluene

加入氢化钠(0.0224g,1.2mmol),氮气置换三次后,加入无水四氢呋喃(5mL),并在搅拌下加入吗啉(0.0523g,0.6mmol),搅拌一小时后,向其中依次加入三[2-(5-乙基呋喃基)]膦(0.0190g,0.06mmol),二(乙酰丙酮)钯(0.0046g,0.015mmol),5-甲氧基-2-苯基苄氯(0.0698g,0.3mmol);混合物在40℃下反应12小时。柱层析分离(硅胶,200-300目;展开剂,石油醚/乙酸乙酯=10/1,v/v),得5-甲氧基-4-吗啉基-2-苯基甲苯0.045g,产率53%。Sodium hydride (0.0224 g, 1.2 mmol) was added, and after nitrogen replacement three times, anhydrous tetrahydrofuran (5 mL) was added, and morpholine (0.0523 g, 0.6 mmol) was added under stirring. After stirring for one hour, tri[ 2-(5-Ethylfuryl)]phosphine (0.0190g, 0.06mmol), bis(acetylacetonate)palladium (0.0046g, 0.015mmol), 5-methoxy-2-phenylbenzyl chloride (0.0698g, 0.3 mmol); the mixture was reacted at 40°C for 12 hours. Column chromatography separation (silica gel, 200-300 mesh; developing solvent, petroleum ether/ethyl acetate=10/1, v/v) to obtain 5-methoxy-4-morpholinyl-2-phenyltoluene 0.045 g, 53% yield.

Figure BDA0003663655340000061
5-甲氧基-4-吗啉基-2-苯基甲苯
Figure BDA0003663655340000061
5-Methoxy-4-morpholinyl-2-phenyltoluene

Colorless oil.1H NMR(400MHz,CDCl3)δ7.42–7.37(m,2H),7.34–7.28(m,3H),6.80(s,1H),6.76(s,1H),3.93–3.86(m,7H),3.11–3.02(m,4H),2.24(s,3H).13C NMR(101MHz,CDCl3)δ151.3,142.0,138.9,134.4,129.9,129.4,128.1,126.5,119.8,113.4,67.2,55.6,51.4,20.1.IR(neat):υmax 2955,2852,2816,1605,1513,1490,1233,1119,1050,870,704,563cm-1;HRMS(ESI)m/z calcd for C18H22NO2[M+H]+:284.1645,found:284.1638.Colorless oil. 1 H NMR (400 MHz, CDCl 3 ) δ 7.42–7.37 (m, 2H), 7.34–7.28 (m, 3H), 6.80 (s, 1H), 6.76 (s, 1H), 3.93–3.86 ( m, 7H), 3.11–3.02 (m, 4H), 2.24 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 151.3, 142.0, 138.9, 134.4, 129.9, 129.4, 128.1, 126.5, 119.8, 113.4, 67.2,55.6,51.4,20.1.IR(neat):υ max 2955,2852,2816,1605,1513,1490,1233,1119,1050,870,704,563cm -1 ; HRMS(ESI)m/z calcd for C 18 H 22 NO 2 [M+H] + :284.1645,found:284.1638.

实施例4:4-吗啉基-2,5-二苯基甲苯的合成Example 4: Synthesis of 4-morpholino-2,5-diphenyltoluene

加入氢化钠(0.0224g,1.2mmol),氮气置换三次后,加入无水四氢呋喃(5mL),并在搅拌下加入吗啉(0.0523g,0.6mmol),搅拌一小时后,向其中依次加入三(2-呋喃基)膦(0.0139g,0.06mmol),二(乙酰丙酮)钯(0.0046g,0.015mmol),2,5-二苯基苄氯(0.0836g,0.3mmol);混合物在40℃下反应12小时。柱层析分离(硅胶,200-300目;展开剂,石油醚/乙酸乙酯=15/1,v/v),得4-吗啉基-2,5-二苯基甲苯0.050g,产率51%。Sodium hydride (0.0224 g, 1.2 mmol) was added, and after nitrogen replacement three times, anhydrous tetrahydrofuran (5 mL) was added, and morpholine (0.0523 g, 0.6 mmol) was added under stirring, and after stirring for one hour, three ( 2-Furyl)phosphine (0.0139 g, 0.06 mmol), bis(acetylacetonate)palladium (0.0046 g, 0.015 mmol), 2,5-diphenylbenzyl chloride (0.0836 g, 0.3 mmol); mixture at 40°C The reaction was carried out for 12 hours. Column chromatography separation (silica gel, 200-300 mesh; developing solvent, petroleum ether/ethyl acetate=15/1, v/v), 0.050 g of 4-morpholino-2,5-diphenyltoluene was obtained, the product was rate 51%.

Figure BDA0003663655340000071
4-吗啉基-2,5-二苯基甲苯
Figure BDA0003663655340000071
4-Morpholinyl-2,5-diphenyltoluene

Yellow solid.1H NMR(400MHz,CDCl3)δ7.77–7.72(m,2H),7.51–7.41(m,7H),7.37–7.33(m,1H),7.23(s,1H),6.95(s,1H),3.67–3.62(m,4H),2.89–2.85(m,4H),2.31(s,3H).13C NMR(101MHz,CDCl3)δ147.8,141.9,141.7,140.7,133.9,133.6,129.6,129.2,128.9,128.3,128.2,127.0,126.9,119.7,67.0,51.7,19.6.IR(KBr):υmax 3056,3023,2852,1781,1683,1600,1512,1483,1446,1118,773,701cm-1;HRMS(ESI)m/z calcd forC23H24NO[M+H]+:330.1852,found:330.1846.Yellow solid. 1 H NMR (400 MHz, CDCl 3 ) δ 7.77–7.72 (m, 2H), 7.51–7.41 (m, 7H), 7.37–7.33 (m, 1H), 7.23 (s, 1H), 6.95 ( s, 1H), 3.67–3.62 (m, 4H), 2.89–2.85 (m, 4H), 2.31 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 147.8, 141.9, 141.7, 140.7, 133.9, 133.6 ,129.6,129.2,128.9,128.3,128.2,127.0,126.9,119.7,67.0,51.7,19.6.IR(KBr):υ max 3056,3023,2852,1781,1683,1600,1512,1483,1446,1118, 773,701cm -1 ; HRMS (ESI) m/z calcd for C 23 H 24 NO[M+H] + : 330.1852, found: 330.1846.

实施例5:4-吗啉基-2-(4-甲氧基苯基)甲苯的合成Example 5: Synthesis of 4-morpholino-2-(4-methoxyphenyl)toluene

加入氢化钠(0.0224g,1.2mmol),氮气置换三次后,加入无水四氢呋喃(5mL),并在搅拌下加入吗啉(0.0523g,0.6mmol),搅拌一小时后,向其中依次加入三(2-噻吩基)膦(0.0168g,0.06mmol),醋酸钯(0.0034g,0.015mmol),2-(4-甲氧基苯基)苄氯(0.0698g,0.3mmol);混合物在40℃下反应12小时。柱层析分离(硅胶,200-300目;展开剂,石油醚/乙酸乙酯=15/1,v/v),得4-吗啉基-2-(4-甲氧基苯基)甲苯0.047g,产率55%。Sodium hydride (0.0224 g, 1.2 mmol) was added, and after nitrogen replacement three times, anhydrous tetrahydrofuran (5 mL) was added, and morpholine (0.0523 g, 0.6 mmol) was added under stirring, and after stirring for one hour, three ( 2-Thienyl)phosphine (0.0168 g, 0.06 mmol), palladium acetate (0.0034 g, 0.015 mmol), 2-(4-methoxyphenyl)benzyl chloride (0.0698 g, 0.3 mmol); mixture at 40°C The reaction was carried out for 12 hours. Column chromatography separation (silica gel, 200-300 mesh; developing solvent, petroleum ether/ethyl acetate=15/1, v/v) to obtain 4-morpholino-2-(4-methoxyphenyl)toluene 0.047 g, 55% yield.

Figure BDA0003663655340000081
4-吗啉基-2-(4-甲氧基苯基)甲苯
Figure BDA0003663655340000081
4-Morpholinyl-2-(4-methoxyphenyl)toluene

Colorless oil.1H NMR(400MHz,CDCl3)δ7.29(d,J=7.8Hz,2H),7.20(d,J=8.2Hz,1H),7.02–6.96(m,2H),6.88–6.82(m,2H),3.91–3.86(m,7H),3.21–3.16(m,4H),2.23(s,3H).13C NMR(101MHz,CDCl3)δ158.6,149.4,142.2,134.8,131.0,130.2,127.2,117.7,114.7,113.5,67.0,55.3,49.8,19.5.IR(neat):υmax 2957,2854,1608,1497,1450,1293,1244,1176,1122,1043,946,834;HRMS(ESI)m/z calcd for C18H22NO2[M+H]+:284.1645,found:284.1638.Colorless oil. 1 H NMR (400 MHz, CDCl 3 ) δ 7.29 (d, J=7.8 Hz, 2H), 7.20 (d, J=8.2 Hz, 1H), 7.02–6.96 (m, 2H), 6.88–6.82 (m, 2H), 3.91–3.86 (m, 7H), 3.21–3.16 (m, 4H), 2.23 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 158.6, 149.4, 142.2, 134.8, 131.0, HRMS (ESI )m/z calcd for C 18 H 22 NO 2 [M+H] + :284.1645,found:284.1638.

对比例1:4-吗啉基-2-(4-甲氧基苯基)甲苯的合成Comparative Example 1: Synthesis of 4-morpholinyl-2-(4-methoxyphenyl)toluene

Figure BDA0003663655340000082
Figure BDA0003663655340000082

沿用已有[J Am Chem Soc,2012,134(12):5492-5495]4-[1-(4-甲基萘基)]吗啉的合成方法。在25mL反应器中,加入氢化钠(0.0480g,2.0mmol)和四(三苯基膦)钯(0.029g,0.025mmol),氮气置换三次后,在氮气保护下加入无水四氢呋喃(5mL),搅拌下加入吗啉(0.0871g,1.0mmol)和1-氯甲基萘(0.0883g,0.5mmol),室温搅拌12小时,柱层析分离(硅胶,200-300目;展开剂,石油醚/乙酸乙酯=10/1,v/v),得4-[1-(4-甲基萘基)]吗啉0.084g,产率为74%。The existing synthesis method of [J Am Chem Soc, 2012, 134(12):5492-5495]4-[1-(4-methylnaphthyl)]morpholine was used. In a 25 mL reactor, sodium hydride (0.0480 g, 2.0 mmol) and tetrakis(triphenylphosphine) palladium (0.029 g, 0.025 mmol) were added, and after nitrogen replacement three times, anhydrous tetrahydrofuran (5 mL) was added under nitrogen protection, Morpholine (0.0871 g, 1.0 mmol) and 1-chloromethylnaphthalene (0.0883 g, 0.5 mmol) were added under stirring, stirred at room temperature for 12 hours, and separated by column chromatography (silica gel, 200-300 mesh; developing solvent, petroleum ether/ Ethyl acetate=10/1, v/v) to obtain 0.084 g of 4-[1-(4-methylnaphthyl)]morpholine with a yield of 74%.

Figure BDA0003663655340000091
Figure BDA0003663655340000091

使用[J Am Chem Soc,2012,134(12):5492-5495]已有方法,尝试进行4-吗啉基-2-苯基甲苯的合成。在25mL反应器中,加入氢化钠(0.0480g,2.0mmol)和四(三苯基膦)钯(0.029g,0.025mmol),氮气置换三次后,在氮气保护下加入无水四氢呋喃(5mL),搅拌下加入吗啉(0.0871g,1.0mmol)和2苯基苄氯(0.1013g,0.5mmol),室温搅拌12小时。柱层析分离(硅胶,200-300目;展开剂,石油醚/乙酸乙酯=10/1,v/v),得4-吗啉基-2-苯基甲苯0.011g,收率9%。An attempt was made to synthesize 4-morpholino-2-phenyltoluene using the existing method in [J Am Chem Soc, 2012, 134(12):5492-5495]. In a 25 mL reactor, sodium hydride (0.0480 g, 2.0 mmol) and tetrakis(triphenylphosphine) palladium (0.029 g, 0.025 mmol) were added, and after nitrogen replacement three times, anhydrous tetrahydrofuran (5 mL) was added under nitrogen protection, Morpholine (0.0871 g, 1.0 mmol) and 2-phenylbenzyl chloride (0.1013 g, 0.5 mmol) were added with stirring, and the mixture was stirred at room temperature for 12 hours. Column chromatography separation (silica gel, 200-300 mesh; developing solvent, petroleum ether/ethyl acetate=10/1, v/v) to obtain 0.011 g of 4-morpholino-2-phenyltoluene, yield 9% .

Figure BDA0003663655340000092
4-(4-吗啉基)-2-苯基甲苯
Figure BDA0003663655340000092
4-(4-Morpholinyl)-2-phenyltoluene

1H NMR(600MHz,CDCl3)δ7.33(t,J=7.5Hz,2H),7.29–7.22(m,3H),7.10(d,J=8.3Hz,1H),6.77(dd,J=8.3,2.8Hz,1H),6.73(d,J=2.8Hz,1H),3.82–3.76(m,4H),3.10–3.04(m,4H),2.11(s,3H).13C NMR(151MHz,CDCl3)δ149.3,142.6,142.4,131.0,129.1,128.1,127.0,126.8,117.5,114.9,67.0,49.8,19.5.IR(neat):υmax 3048,3023,2954,2848,1609,1488,1449,1377,1336,1122,945,704cm-1;HRMS(ESI)m/z calcd for C17H20NO[M+H]+:254.1539,found:254.1535. 1 H NMR (600 MHz, CDCl 3 ) δ 7.33 (t, J=7.5 Hz, 2H), 7.29-7.22 (m, 3H), 7.10 (d, J=8.3 Hz, 1H), 6.77 (dd, J= 8.3, 2.8Hz, 1H), 6.73 (d, J=2.8Hz, 1H), 3.82–3.76 (m, 4H), 3.10–3.04 (m, 4H), 2.11 (s, 3H). 13 C NMR (151MHz) ,CDCl 3 )δ149.3,142.6,142.4,131.0,129.1,128.1,127.0,126.8,117.5,114.9,67.0,49.8,19.5.IR(neat):υ max 3048,3023,2954,2848,1609,1488,1449 , 1377, 1336, 1122, 945, 704 cm -1 ; HRMS(ESI) m/z calcd for C 17 H 20 NO[M+H] + : 254.1539, found: 254.1535.

对比例2:4-吗啉基-2-苯基甲苯的合成Comparative Example 2: Synthesis of 4-morpholino-2-phenyltoluene

Figure BDA0003663655340000093
Figure BDA0003663655340000093

Figure BDA0003663655340000101
Figure BDA0003663655340000101

实验条件:在25mL反应器中,加入碱(1.2mmol),氮气置换三次后,加入无水溶剂(5mL),并在搅拌下加入吗啉(0.0523g,0.6mmol),搅拌一小时后,向其中依次加入配体(0.06mmol),金属催化剂(0.015mmol),2-苯基苄氯(0.0608g,0.3mmol);混合物在40℃下反应12小时。产物收率通过反应液核磁确定。实验结果如表格所示。产物纯化方法同实施实例4。Experimental conditions: In a 25 mL reactor, add a base (1.2 mmol), after nitrogen replacement three times, add an anhydrous solvent (5 mL), and add morpholine (0.0523 g, 0.6 mmol) under stirring, and after stirring for one hour, add The ligand (0.06 mmol), the metal catalyst (0.015 mmol), and 2-phenylbenzyl chloride (0.0608 g, 0.3 mmol) were sequentially added therein; the mixture was reacted at 40° C. for 12 hours. The product yield was determined by NMR of the reaction solution. The experimental results are shown in the table. The product purification method is the same as that in Example 4.

Claims (6)

1.一种多取代芳香胺类化合物的制备方法,其特征在于,以含苄基卤代物及其衍生物为原料,在金属催化剂、配体、碱的作用下,在无水有机溶剂中,胺类化合物与原料结合,得到多取代的芳胺类化合物,合成路线如下:1. a preparation method of a polysubstituted aromatic amine compound, is characterized in that, with containing benzyl halide and derivative thereof as raw material, under the effect of metal catalyst, ligand, alkali, in anhydrous organic solvent, Amine compounds are combined with raw materials to obtain polysubstituted aromatic amine compounds. The synthetic route is as follows:
Figure FDA0003663655330000011
Figure FDA0003663655330000011
反应温度在40℃,反应时间12小时;The reaction temperature was 40°C, and the reaction time was 12 hours; R1选自氢、芳基;R 1 is selected from hydrogen, aryl; R2选自氢、甲氧基、芳基;R 2 is selected from hydrogen, methoxy, aryl; R3为芳基;R 3 is aryl; R4为烷基;R 4 is alkyl; R5为烷基;R 5 is alkyl; X选自氯、溴;X is selected from chlorine, bromine; 含苄基卤代物及其衍生物与碱的摩尔比为1:4;The molar ratio of benzyl halide and its derivatives to base is 1:4; 含苄基卤代物及其衍生物与金属催化剂的摩尔比为1:0.05;The molar ratio of benzyl halide and its derivatives to metal catalyst is 1:0.05; 含苄基卤代物及其衍生物与配体的摩尔比为1:0.2;The molar ratio of benzyl halide and its derivatives to ligand is 1:0.2; 含苄基卤代物及其衍生物的摩尔浓度为0.06mmol/mL;The molar concentration of benzyl halide and its derivatives is 0.06mmol/mL; 含苄基卤代物及其衍生物与胺类化合物的摩尔比为1:2。The molar ratio of the benzyl halide and its derivatives to the amine compound is 1:2.
2.如权利要求1中所述的制备方法,其特征还在于,所述的胺类化合物包括一元胺化合物和二元胺化合物。2 . The preparation method according to claim 1 , wherein the amine compound includes a monoamine compound and a diamine compound. 3 . 3.如权利要求1中所述的制备方法,其特征还在于,所述的碱为氢化钠。3. preparation method as described in claim 1 is characterized in that, described alkali is sodium hydride. 4.如权利要求1中所述的制备方法,其特征还在于,所述的金属催化剂包括醋酸钯、二(乙酰丙酮)钯。4. The preparation method according to claim 1, wherein the metal catalyst comprises palladium acetate and bis(acetylacetonate) palladium. 5.如权利要求1中所述的制备方法,其特征还在于,所述的配体包括三(2-呋喃基)磷、三[2-(5-甲基呋喃基)]膦、三[2-(5-乙基呋喃基)]膦、三(2-噻吩基)膦。5. The preparation method according to claim 1, wherein the ligand comprises tris(2-furyl) phosphorus, tris[2-(5-methylfuryl)]phosphine, tris[ 2-(5-ethylfuryl)]phosphine, tris(2-thienyl)phosphine. 6.如权利要求1中所述的制备方法,其特征还在于,所述的无水溶剂为四氢呋喃。6. The preparation method according to claim 1, wherein the anhydrous solvent is tetrahydrofuran.
CN202210580811.8A 2022-05-26 2022-05-26 Preparation method of polysubstituted arylamine compound Withdrawn CN114773253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210580811.8A CN114773253A (en) 2022-05-26 2022-05-26 Preparation method of polysubstituted arylamine compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210580811.8A CN114773253A (en) 2022-05-26 2022-05-26 Preparation method of polysubstituted arylamine compound

Publications (1)

Publication Number Publication Date
CN114773253A true CN114773253A (en) 2022-07-22

Family

ID=82407968

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210580811.8A Withdrawn CN114773253A (en) 2022-05-26 2022-05-26 Preparation method of polysubstituted arylamine compound

Country Status (1)

Country Link
CN (1) CN114773253A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102558095A (en) * 2011-12-13 2012-07-11 大连理工大学 Method for preparing aromatic amine compound
CN106478387A (en) * 2016-01-14 2017-03-08 大连理工大学 A kind of preparation method of naphthyl containing α two arone compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102558095A (en) * 2011-12-13 2012-07-11 大连理工大学 Method for preparing aromatic amine compound
CN106478387A (en) * 2016-01-14 2017-03-08 大连理工大学 A kind of preparation method of naphthyl containing α two arone compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHENG ZHANG等: ""Palladium-Catalyzed Amination of Chloromethylnaphthalene and Chloromethylanthracene Derivatives with Various Amines"", 《J. AM. CHEM. SOC.》, vol. 134, pages 5492 - 5495 *

Similar Documents

Publication Publication Date Title
Tu et al. A highly efficient precatalyst for amination of aryl chlorides: synthesis, structure and application of a robust acenaphthoimidazolylidene palladium complex
CN103408445B (en) A kind of arylamine derivative and preparation method thereof
CN107325018B (en) β-trifluoromethyl enamine derivates and preparation method thereof
CN109320434A (en) Application of ionic iron(III) complexes as catalysts in the preparation of benzylamines
CN108380245A (en) A kind of novel bidentate phosphorus-azepine Cabbeen p-cymene type catalyzed by ruthenium complexes agent and preparation method thereof and synthesis application
CN115448909B (en) N-carbazolyl-1H-pyrrole-2-carboxamide and its application as ligand in copper-catalyzed C-N coupling reaction
CN110423217B (en) Preparation method of conjugated eneyne compound
US11890602B2 (en) Application of the ionic iron (III) complex as catalyst in preparation of benzylamine compound
CN110041235A (en) A kind of N- phenyl-N- p-toluenesulfonyl trifluoroacetamide and application
CN102558095A (en) Method for preparing aromatic amine compound
KR101614887B1 (en) Method for preparation of amide and imide from alcohol and nitrogen Containing Compound
CN110449183A (en) Ionic iron (III) complex is preparing the application in allylic amines compound
CN114773253A (en) Preparation method of polysubstituted arylamine compound
CN108046978A (en) A kind of efficient method for preparing iodate benzyl and its derivative
CN115572239B (en) Method for preparing alpha-ketoamide compound
US11873265B2 (en) Method for preparing benzyl amine compound
CN102153483B (en) Axial chirality vicinal diamine compound and preparation method thereof
CN114907404A (en) 5-(2-(Disubstituted phosphino)phenyl)-1-alkyl-1H-pyrazolephosphine ligand and preparation method and application thereof
CN106543040B (en) A kind of synthetic method of medicine intermediate carbamate compounds
CN116836062B (en) Preparation method of N, N-dimethyl-1-naphthylamine compound
CN104610002B (en) A kind of method of aryl hydrazine synthesis symmetry biphenyl
CN116462579B (en) A preparation method of spirofluorene anthrone compound
CN110003062B (en) A kind of N-phenyl-N-p-toluenesulfonyl difluoroacetamide and application
CN115368244B (en) Synthesis method of 2-aryl-2-(4-aminophenyl)propane
CN116675617B (en) A method for synthesizing non-cyclic tertiary amide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20220722

WW01 Invention patent application withdrawn after publication